NMFC Q3 2025 Earnings Call Transcript

New Mountain Finance reported adjusted net investment income of $0.32 per share, fully covering its $0.32 dividend, while NAV fell $0.15 to $12.06 per share. The company also authorized an additional $100 million share repurchase program and is exploring up to a $500 million portfolio sale to reduce concentration and PIK income. Credit metrics remain generally stable, though Beauty Industry Group was moved to nonaccrual, bringing total nonaccruals to $51 million, or 1.7% of fair value.

Analysis

NMFC is using the equity discount as a capital-allocation lever rather than a signal to retrench. The buyback plus potential asset sale creates a self-reinforcing loop: shrink lower-return or more concentrated exposures, recycle proceeds into repurchases, and lift NAV/share even if gross assets come down. That matters because a BDC trading below book can compound value faster by reducing share count than by marginally growing the loan book, especially when new loan spreads are tighter and leverage is already near the top of management's range.

The more interesting second-order effect is portfolio quality drift in the right direction. Moving from second lien toward first lien and from noncash toward cash income should reduce volatility in distributable earnings, but it also likely lowers headline yield over time; the market may initially misread that as negative. In reality, a modest lower-yield / lower-loss profile is exactly what should narrow the discount to book, particularly if the company continues to demonstrate coverage without leaning on fee waivers or cyclical rate tailwinds.

Credit risk looks contained for now, but the book is more idiosyncratic than the headline metrics imply. Beauty Industry Group is a warning that tariff exposure and consumer softness can still break through even in a "defensive" underwriting framework, and Edmentum shows how capital-structure complexity can cap equity upside even when operating performance is stable. The catalyst path is clear over the next 1-2 quarters: if repayments stay strong and management executes a partial sale without sacrificing marks, the discount should compress; if not, the stock remains a high-yield value trap with buybacks masking slower organic growth.

Key Decisions for Investors

• Long NMFC common vs. short a broader BDC basket (e.g., ARCC/OCSL/MAIN pair) for 3-6 months: thesis is discount-to-book narrowing via buybacks and asset rotation; stop if the discount fails to close after the next quarterly update.
• Buy NMFC on weakness below roughly 0.85x book and/or near $10.25-$10.50: asymmetry improves because repurchases are accretive at current levels and management has shown willingness to lean into the spread.
• For income portfolios, prefer NMFC common over unsecured BDC credit only if you can tolerate mark risk; otherwise avoid adding at current yield until the sale process or buyback pace provides a clearer catalyst.
• Express a cautious bullish view with short-dated covered calls on existing NMFC longs (1-2 quarters out): harvest rich yield while capping upside if the market is slow to rerate the discount.
• Watch for a post-February catalyst trade: if the portfolio sale is confirmed and size is meaningful, add to NMFC as a catalyst-driven re-rating idea; if it is delayed or diluted, fade rallies because the market will likely refocus on limited organic growth.